Ryman Healthcare - Running Ryman for Cash
We value RYM using our annuity earnings including resale gains and a dividend discount model (DDM). We reinstate our rating at NEUTRAL.
194 Views
Ryman Healthcare - NZ$1bn Equity Raise and Market Update
Ryman Healthcare (RYM) is raising NZ$1bn in equity to create a sustainable capital structure, reducing September 2024 pro-forma gearing from 37.3%...
496 Views
Ryman Healthcare - 1H25 Result — Structural Gain, Cyclical Pain
Ryman Healthcare (RYM) used to dress up weak results to make them look good. In the last two results the opposite has been true.
410 Views
Ryman Healthcare - 1H25 Preview — Let Go of Yesterday
After it lifted the veil on a decade of opaque accounting practices and half truths at its FY24 result, we expect its 1H25 result to be a...
269 Views
Ryman Healthcare - Taking Action; Steps 3, 4, 5 and 9. More to Come
Ryman Healthcare (RYM) announced the first part of its Business Improvement Program (BIP), with a focus on increasing prices, reducing costs and...
283 Views